Maze Therapeutics, Inc. · NASDAQ:MAZE
Deep Track Capital, LP reported a 6.91% stake in Maze Therapeutics, Inc. (Schedule 13G)
Event Jan 31, 2025 · Filed Feb 7, 2025
Deep Track Capital, LP reported a 6.91% stake in Maze Therapeutics, Inc., 3,023,484 shares, as a passive investor on Jan 31, 2025. Filed Feb 7, 2025 (Schedule 13G).
- Stake
- 6.91%
- Shares
- 3,023,484
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deep Track Capital, LP | 6.91% | 3,023,484 |
| Deep Track Biotechnology Master Fund, Ltd. | 6.91% | 3,023,484 |
| David Kroin | 6.91% | 3,023,484 |
Source
Related
- Maze Therapeutics, Inc.
- Deep Track Capital, LP
- Maze Therapeutics, Inc. shareholders
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2025
- Form 4 · Bernstein Harold · Oct 2, 2026
- Form 4 · Coloma Jason V · Oct 2, 2026
- Form 4 · Dandekar Atul · Oct 1, 2026
- Form 4 · Bernstein Harold · Sep 8, 2026
- Form 4 · Bernstein Harold · Sep 4, 2026